Riskpilot← Back to searchSign inGet full accessTipamedi Oy
OYActiveY-tunnus 0558738-1Koskelankatu 9Manufacture of medical and dental instruments and supplies · NACE 3250Est. 1984— employees
Revenue 2024
EUR 674K
+4% vs 2023
EBITDA margin
46.6%
-7% vs 2023
Equity ratio
96.6%
Financial strength
Net profit 2024
EUR 237K
+1% vs 2023
| Revenue | EUR 674K | +4% |
| EBITDA | EUR 314K | -7% |
| Net profit | EUR 237K | +1% |
| Total assets | EUR 1,6M | +8% |
| Equity | EUR 1,5M | +8% |
| Employees | — | — |
Legal name
Tipamedi Oy
Y-tunnus number
0558738-1
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
8. kesäkuuta 1984
Share capital
EUR 2 523
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on terveydenhuoltopalveluiden tuottaminen, ostaminen ja välittäminen; lääketieteellinen tutkimus, lääkkeiden, lääkintälaitteiden ja lääketieteellisten apuvälineiden ja implantaattien kehitys ja markkinointi; tietotekniikka- ja tietoliikennealan konsultointi ja alan laitteiden kehitys ja markkinointi; toimistotarvikkeiden, puuesineiden, korujen sekä ajoneuvoteknisten laitteiden ja osien kehitys ja markkinointi; ajoneuvojen, asuntovaunujen ja asuntoautojen, veneiden ja kiinteistöjen omistaminen, myynti, vuokraus ja välittäminen; kaivostoiminta, maanrakennusurakointi ja alan koneiden ja laitteiden ostaminen, myynti, vuokraus ja välittäminen; matkailupalveluiden tuottaminen; arvopaperikaupan harjoittaminen sekä kaikki muut lailliset toimialat.
Address
Koskelankatu 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 302 | 315 | 714 | 814 | 449 | 651 | 674 |
| Staff expenses | −75 | −78 | −71 | −78 | −52 | −53 | −60 |
| EBITDA | 162 | 234 | 250 | 325 | 206 | 337 | 314 |
| Depreciation & amort. | −11 | −30 | −22 | −31 | −32 | −24 | −18 |
| EBIT | 150 | 204 | 228 | 294 | 174 | 312 | 296 |
| Net financials | 15 | 32 | −11 | 9 | −51 | −19 | 0 |
| Profit before tax | 165 | 237 | 217 | 302 | 124 | 293 | 296 |
| Tax | 34 | 47 | 47 | 78 | 29 | 59 | 59 |
| Net profit | 132 | 190 | 170 | 225 | 95 | 234 | 237 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 025 | 1 134 | 1 281 | 1 374 | 1 385 | 1 468 | 1 592 |
| Equity | 1 018 | 1 127 | 1 207 | 1 322 | 1 303 | 1 424 | 1 537 |
| Long-term debt | 3 | 1 | 1 | 4 | 4 | 4 | 3 |
| Short-term debt | 4 | 6 | 74 | 48 | 0 | 40 | 51 |
| Total debt | 7 | 7 | 75 | 52 | 4 | 44 | 55 |
EBITDA margin
46.6%
This company
15.8%
Market median
+195% vs market
20182024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20182024
Return on equity
15.4%
This company
18.4%
Market median
+16% vs market
20182024
Net profit margin
35.2%
This company
8.1%
Market median
+335% vs market
20182024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20182024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JO Audit | Audit | 2018 | — | — |
JP | Audit | 2026 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
VE Deputy Member | Deputy Member | 2017 | — | — |
TJ Deputy auditor | Deputy auditor | 2026 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tipamedi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juha Olavi Koponen | Audit | 0 companies |
| Jonne Petter Granqvist | Audit | 0 companies |
| Timo Juhani Parkkila | Chief Executive Officer | 0 companies |
| Vilma Eeva Maria Parkkila | Deputy Member | 0 companies |
| Tom Jukka Pekka Lindblom | Deputy auditor | 0 companies |